Label (Lbl713359740)
Pregabalin Capsule
Product Images NDC 71335-9740
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71335-9740). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Pregabalin Fig01)
Figure 2 (Pregabalin Fig02)
Figure 3 (Pregabalin Fig03)
Figure 4 (Pregabalin Fig04)
Figure 5 (Pregabalin Fig05)
Figure 6 (Pregabalin Fig06)
Figure 7 (Pregabalin Fig07)
Figure 9 (Pregabalin Fig08)
Figure 10 (Pregabalin Fig09)
Figure 11 (Pregabalin Fig10)
Figure 12 (Pregabalin Fig11)
The text provided is a table showing the percentage improvement of subjects for different treatment groups (Pregabalin and Placebo) over a 16-week period. The table includes numbers ranging from 100 to 280 in increments of 10, indicating the percent improvement from baseline to week 16 for each group.*
Cockcroft And Gault Equation (Pregabalin Formula)
This is a calculation for estimating CLCT (clearance of creatinine) in patients. It involves multiplying the difference between 140 and the patient's age (in years) by their weight (in kg). For female patients, the result is then multiplied by 0.85. The final step is to multiply the result by the serum creatinine level (in mg/dL), which is measured in the blood.*
Chemical Structure (Pregabalin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
